Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.

Organic/inorganic nanocomposites for cancer immunotherapy


Cancer immunotherapy provides an effective way to deal with cancer. Although immunotherapy strategies have shown encouraging therapeutic effects, the inherent limitations of immunotherapy, such as multiple tumor immune evasion methods, low responsive rate, and systemic toxicity, still hinder its clinical applications. In recent decades, nanomaterials are considered promising in cancer immunotherapy since they can realize targeted delivery and interact with the immune system to induce or enhance the antitumor immune responses. Among them, organic/inorganic nanocomposites are ideal candidates for cancer immunotherapy since they could combine both advantages of organic and inorganic components. Multifunctional organic/inorganic nanocomposites could help overcome the shortcomings of current cancer immunotherapy, and realize the combination of immunotherapy and other therapeutic strategies with synergistic antitumor effect. Herein, we review the recent progress of organic/inorganic nanocomposites designed for cancer immunotherapy. The immunotherapy strategies of nanocomposites are summarized from the perspective of achieving immune enhancement. The challenges of nanocomposites in cancer immunotherapy are also discussed.

Back to tab navigation

Article information

15 May 2020
12 Jun 2020
First published
13 Jun 2020

Mater. Chem. Front., 2020, Accepted Manuscript
Article type
Review Article

Organic/inorganic nanocomposites for cancer immunotherapy

M. Hao, B. Chen, X. Zhao, N. Zhao and F. Xu, Mater. Chem. Front., 2020, Accepted Manuscript , DOI: 10.1039/D0QM00323A

Social activity

Search articles by author